CooperCompanies wraps up acquisition of Generate Life Sciences for $1.6bn
Generate Life Sciences offers reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Dec 21
Generate Life Sciences offers reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services
20 Dec 21
The non-invasive test is suitable for any individual, including those suspected of Covid-19 and those without symptoms
20 Dec 21
Optimum TAV is a low profile, self-expanding valve, containing a nickel-titanium (nitinol) frame and bovine pericardial tissue leaflets
20 Dec 21
BD COR MX for infectious disease testing has been granted CE mark approval and is the final instrument…
20 Dec 21
Subject to positive study results, the number of patients currently enrolled in ECLIPSE is targeted to support a…
20 Dec 21
The simple test allows individuals to safely, quickly, and effectively obtain real-time measurements of their current COVID-19 immunity…
20 Dec 21
Physicians need all options available to support unknown emergent cases; hospitals need tools designed to optimize workflow and…
17 Dec 21
The proceeds will be utilised by Tasso to scale manufacturing and operations to meet the increased demand for…
17 Dec 21
The FDA Breakthrough Device Designation helps patients with ESRD vein dilation indication to have enhanced access to FA-1…
17 Dec 21
The geko device is said to enhance blood flow in lower limb soft tissue for patients with venous…